I-Mab has laid off almost a third of its employees as part of a restructuring effort, the company disclosed in a recent ...

Chinese biotech company Vigonvita Life Sciences has filed for an initial public offering (IPO) on the Hong Kong Stock ...

The company earlier announced that the primary endpoint was met in a randomized, double-blind, placebo-controlled Phase IIb ...

US mRNA specialist Moderna demonstrated substantial R&D investment and progress in the UK, two years since signing its ...

The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...

Fondazione Telethon, an Italian biomedical charity focused on rare genetic diseases, has submitted a Marketing Authorization ...

Russia plans to significantly expand the geography of the export of its drugs this year, paying attention both to emerging ...

California-based ImmunityBio has entered into a collaboration and supply agreement with Sino-American biotech BeiGene (to be ...

Faisal Sukhtian has been appointed as chairman of the board of directors at Outlook Therapeutics, effective immediately.

Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...